Three dimensional structure directs T-cell epitope dominance associated with allergy.
BACKGROUND
CD4+ T-cell epitope immunodominance is not adequately explained by peptide selectivity in class II major histocompatibility proteins, but it has been correlated with adjacent segments of conformational flexibility in several antigens.


METHODS
The published T-cell responses to two venom allergens and two aeroallergens were used to construct profiles of epitope dominance, which were correlated with the distribution of conformational flexibility, as measured by crystallographic B factors, solvent-accessible surface, COREX residue stability, and sequence entropy.


RESULTS
Epitopes associated with allergy tended to be excluded from and lie adjacent to flexible segments of the allergen.


CONCLUSIONS
During the initiation of allergy, the N- and/or C-terminal ends of proteolytic processing intermediates were preferentially loaded into antigen presenting proteins for the priming of CD4+ T cells.
Melton
Scott J
SJ
Biomedical Sciences Graduate Program, Tulane University Health Sciences Center, New Orleans, LA, 70112, USA. smelton@tulane.edu.
Landry
Samuel J
SJ
J Mol Biol. 2000 Jan 7;295(1):7-16
10623504
J Allergy Clin Immunol. 2007 Apr;119(4):780-91
17321578
Biochemistry. 2003 Mar 25;42(11):3203-13
12641451
J Mol Graph. 1996 Feb;14(1):51-5, 29-32
8744573
Nucleic Acids Res. 2003 Jul 1;31(13):3497-500
12824352
J Biol Chem. 2002 Jan 4;277(1):155-60
11673463
Annu Rev Immunol. 2005;23:975-1028
15771591
J Immunol. 1998 Oct 15;161(8):4048-57
9780175
J Biol Chem. 2005 Feb 4;280(5):3740-6
15539389
Immunol Today. 1997 Nov;18(11):527-32
9386348
Biochemistry. 2004 Nov 16;43(45):14420-30
15533047
J Immunol. 1993 Apr 15;150(8 Pt 1):3582-91
7682244
Nat Immunol. 2004 Jul;5(7):685-92
15224094
J Immunol. 2002 Sep 1;169(5):2444-50
12193713
Immunity. 1996 Apr;4(4):357-66
8612130
Biochemistry. 1990 Aug 7;29(31):7133-55
2207096
J Infect Dis. 2000 Mar;181(3):1001-9
10720523
Biol Chem. 2006 Oct-Nov;387(10-11):1503-11
17081125
Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):734-8
8570625
J Immunol. 1995 Feb 15;154(4):1932-40
7530747
J Immunol. 2000 Jul 1;165(1):20-3
10861030
Adv Exp Med Biol. 1996;409:141-6
9095234
Trends Immunol. 2008 Mar;29(3):141-7
18261958
Science. 1990 Dec 14;250(4987):1563-6
2274788
J Immunol. 2007 Jun 1;178(11):7181-9
17513767
J Mol Biol. 1996 Oct 11;262(5):756-72
8876652
Biochemistry. 2006 Oct 10;45(40):12325-33
17014085
J Immunol. 2002 Jul 1;169(1):1-4
12077220
Protein Sci. 1994 May;3(5):757-68
7520312
J Biol Chem. 2001 Nov 9;276(45):41913-20
11551929
J Virol. 2008 Feb;82(3):1238-48
18057238
Nat Immunol. 2002 Feb;3(2):169-74
11812994
J Exp Med. 1997 Aug 18;186(4):549-60
9254653
J Mol Biol. 2006 May 5;358(3):882-904
16542678
Nucleic Acids Res. 2003 Jul 1;31(13):3381-5
12824332
Protein Eng. 1998 May;11(5):349-59
9681867
J Mol Biol. 1999 Jan 15;285(2):627-43
9878434
Eur J Immunol. 2002 Feb;32(2):467-76
11813165
Vaccine. 1997 Feb;15(3):321-4
9139493
J Immunol. 1998 Jul 1;161(1):448-57
9647255
J Biol Chem. 2002 Jan 4;277(1):161-8
11602571
BMC Bioinformatics. 2007 Jul 04;8:238
17608956
Protein Eng Des Sel. 2005 Feb;18(2):59-64
15788422
J Immunol. 1989 Feb 15;142(4):1063-8
2783704
Immunity. 2000 Apr;12(4):391-8
10795737
Proteins. 1989;6(2):87-103
2695928
Eur J Immunol. 2008 May;38(5):1231-7
18398933
Clin Exp Allergy. 2005 Mar;35(3):367-73
15784117
Clin Exp Allergy. 1996 Nov;26(11):1316-28
8955581
Proc Natl Acad Sci U S A. 2005 Mar 29;102(13):4741-6
15774579
Proteins. 1998 Mar 1;30(4):435-41
9533627
Curr Opin Immunol. 2006 Feb;18(1):70-7
16316750
Biopolymers. 2003 Jun;69(2):176-88
12767121
Proteins. 2001 Dec 1;45(4):438-48
11746691
J Immunol. 1998 Apr 1;160(7):3363-73
9531296